Lmito Therapeutics is a clinical-stage pharmaceutical company developing novel therapies for autoinflammatory/autoimmune disorders and fibrotic diseases through metabolic reprogramming of mitochondrial and cellular metabolisms.

Disease Domain	Count

Immune System Diseases	4
Nervous System Diseases	2

Top 5 Drug Type	Count

Chemical drugs	4
Small molecule drug	3

Top 5 Target	Count

SARM1(sterile alpha and TIR motif containing 1)	1
PKM2(Pyruvate kinase isozymes M1/M2)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 16 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Phase 1 Clinical

Current Projects

Drug(Targets)	Indications	Global Highest Phase

LMT-503	Crohn Disease More	Phase 1
Immunometabolism modulator 2 (Lmito Therapeutics)	Rheumatoid Arthritis More	Preclinical
Fibrometabolism modulator 1(Lmito Therapeutics)	Idiopathic Pulmonary Fibrosis More	Preclinical
SARM1 program(Lmito Therapeutics) ( SARM1 )	Nervous System Diseases More	Preclinical
Charcot Marie tooth disease type 1A (Lmito Therapeutics)	Charcot-Marie-Tooth Disease, Type Ia More	Preclinical

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis